Lisinopril, > = 98 %(HPLC)

Code: l6292-250mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lisinopril has been used to study the antifibrotic effect in duchenne muscular dystrophy mice. It has been used to study the changes in renal-structure and -funct...


en savoir plus

Votre prix
$1,021.77 250MG
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lisinopril has been used to study the antifibrotic effect in duchenne muscular dystrophy mice. It has been used to study the changes in renal-structure and -function in TGR(mRen2)27 (transgenic rat harboring the murine Ren-2 gene) rats upon long term darbepoetin α treatment.

Biochem/physiol Actions

Angiotensin converting enzyme (ACE) inhibitor.

Features and Benefits

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

100, 250 mg in glass bottle

assay≥98% (HPLC)
colorwhite
formsolid
Gene Informationhuman ... ACE(1636)
InChI keyCZRQXSDBMCMPNJ-ZUIPZQNBSA-N
InChI1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1
Quality Level100
SMILES string[H]O[H].[H]O[H].NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O
solubilityH2O: ≥10 mg/mL, DMSO: ~6.5 mg/mL (with heating and sonicating)
storage temp.2-8°C
Code
Description
Unité de vente
Prix annoncé
Qté
L6292-100MG
Lisinopril, > = 98 %(HPLC)

Unité:100MG
Prix annoncé: $508.60
Source:Prix annoncé
AJOUTER
Cas Number83915-83-7
Ce produit répond aux critères suivants: